HIV risks high in Mexico City's male sex trade

November 14, 2014

PROVIDENCE, R.I. [Brown University] -- A new study documents the stark health dangers of the male sex trade in the streets, hotels, and discotheques of Mexico City. Lead author and health economist Omar Galárraga's point in making the grim assessment of the legal but perilous market is to find an incentive that might reduce the spread of HIV and other diseases in the nation's community of men who have sex with men.

"It's a very highly at-risk population," said Galárraga, assistant professor of health services, policy and practice in the Brown University School of Public Health. For the study, published in the Journal of the International AIDS Society, his team conducted interviews and infection tests with 267 male sex workers who come to the city's Clínica Especializada Condesa.

Sexually transmitted infections are prevalent among the workers, the study reports. In the sample, 38 percent had HIV, 21 percent had syphilis, 10 percent had chlamydia, 3 percent had active hepatitis B, 2 percent had gonorrhea, and 1 percent had hepatitis C.

Many of the sex workers were not aware of or were confused about their health status. Of the 100 confirmed by testing to have HIV, 14 did not know if they had it, 11 said they did not have it, and another 16 didn't want to say (even though they agreed to testing). Similar rates applied to the other diseases.

The high prevalence of disease (and the lack of personal awareness) is serious because the workers make many sexual contacts every week. On average, the sex workers reported engaging in sex with more than four paying customers and about three non-paying partners in the week prior to their interview. The sex partners were almost always male.

Incentives and disincentives for condom use

One of the best ways to prevent the spread of disease is condom use, but the study found condom use was also lacking. The workers reported using condoms only 78 to 84 percent of the time.

Why isn't condom use more common, given the high risk of becoming seriously ill? One reason the study found is that sex workers can make 34.5 percent more money, on average, if they forgo the condom. The median price they charged for sex was about $32, but workers can earn more than $40 without protection.

With all this information in hand, Galárraga and his colleagues have been working to test an idea for countering the market incentive to forgo condoms and to keep workers connected to health care services, such as infection testing. Their idea is to offer payments in the form of food and grocery vouchers twice a year on the condition that workers use condoms to stay healthy. If follow-up testing shows they don't acquire new diseases, they can get vouchers every six months valued at as much as $75. In a prior study, Galárraga and his colleagues found that workers said they would be willing to change behavior in exchange for that much.

"Avoiding clients who pay higher prices for unprotected sex implies monetary losses for male sex workers," the researchers wrote in the study. "Thus compensation in the form of economic incentives for self-protection can offer one method for reducing risk behaviors and improving individual and population health."

The results of a pilot trial are pending. The researchers hope to expand testing to a wider group. Since performing this study they have been in contact with hundreds more sex workers.

In addition to Galárraga, the study's authors are Sandra G. Sosa-Rubí, Carlos Conde-Glez, and Sergio Bautista-Arredondo of the Instituto Nacional de Salud Pública in Mexico; Andrea González, Florentino Badial-Hernández, and Luis Juárez-Figueroa of Clínica Especializada Condesa in Mexico City; and Caroline Kuo, Don Operario, and Kenneth Mayer of Brown University.
-end-
The U.S. National Institutes of Health (grants R21HD065525, K01 MH096646), The Mexican National Center for HIV/AIDS Control and Prevention (CENSIDA), and Brown University supported the research.

Brown University

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.